Cargando…

The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies

BACKGROUND: Epstein-Barr virus (EBV) is considered to be closely associated with nasopharyngeal carcinoma (NPC), in which EBV-encoded latent membrane protein 1 (LMP1) was found to have an oncogenic role. However, the results published on the LMP1 polymorphism are inconsistent. In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales:	da Costa, Vivaldo G, Marques-Silva, Ariany C, Moreli, Marcos L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404015/ https://www.ncbi.nlm.nih.gov/pubmed/25927427 http://dx.doi.org/10.1186/s13643-015-0037-z

Ejemplares similares

Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia
por: See, Hui Shien, et al.
Publicado: (2008)

Id1 Interacts and Stabilizes the Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) in Nasopharyngeal Epithelial Cells
por: Hau, Pok Man, et al.
Publicado: (2011)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
por: Banko, Ana, et al.
Publicado: (2021)

Interleukins, laminin and epstein - barr virus latent membrane protein 1 (EBV LMP1) Promote metastatic phenotype in nasopharyngeal carcinoma
por: Chew, Michelle MS, et al.
Publicado: (2010)

Epstein–Barr Virus LMP1 Induces Soluble PD-L1 in Nasopharyngeal Carcinoma
por: Kase, Kina, et al.
Publicado: (2021)

Therapeutic vaccine targeting Epstein-Barr virus latent protein, LMP1, suppresses LMP1-expressing tumor growth and metastasis in vivo
por: Lin, Mei-Chun, et al.
Publicado: (2017)

Epstein-Barr virus in gastric cancer and association with 30 bp del-latent membrane protein 1 polymorphism
por: dos Santos, Emília Rosaria Carvalho, et al.
Publicado: (2023)

Overexpression of Epstein-Barr virus-encoded latent membrane protein-1 (LMP-1) in oral squamous cell carcinoma
por: Rahman, Rifat, et al.
Publicado: (2019)

Targeting Epstein–Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy
por: Xiao, L, et al.
Publicado: (2014)

Epstein-Barr Virus LMP1 Modulates the CD63 Interactome
por: Cheerathodi, Mujeeb, et al.
Publicado: (2021)

Colocalization of Interferon Regulatory Factor 7 (IRF7) with Latent Membrane Protein 1 (LMP1) of Epstein-Barr Virus
por: Kim, In-Wook, et al.
Publicado: (2006)

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma
por: Shair, Kathy H. Y., et al.
Publicado: (2012)

Epstein-Barr virus-encoded LMP1 regulated Pim1 kinase expression promotes nasopharyngeal carcinoma cells proliferation
por: Ding, Ran-ran, et al.
Publicado: (2019)

Suppression of Nasopharyngeal and Gastric Tumor Growth in a Mouse Model by Antibodies to Epstein–Barr Virus LMP1 Protein
por: Khenchouche, Abdelhalim, et al.
Publicado: (2023)

Molecular Screening for Epstein-Barr virus (EBV): Detection of Genomic EBNA-1, EBNA-2, LMP-1, LMP-2 Among Vietnamese Patients with Nasopharyngeal Brush Samples
por: Lao, Thuan Duc, et al.
Publicado: (2017)

Epstein-Barr Virus Latent Membrane Protein-1 Expression in Nasopharyngeal Carcinoma
por: Salano, Valerie E., et al.
Publicado: (2021)

The copy number of Epstein-Barr virus latent genome correlates with the oncogenicity by the activation level of LMP1 and NF-κB
por: Zuo, Lielian, et al.
Publicado: (2015)

CRISPR/Cas9-mediated LMP1 knockout inhibits Epstein-Barr virus infection and nasopharyngeal carcinoma cell growth
por: Huo, Haifeng, et al.
Publicado: (2019)

30-bp deletion variant of LMP-1 gene of EBV in HIV+ patients After several years of antiretroviral therapy
por: Cherot, Janine, et al.
Publicado: (2006)

Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition
por: Hannigan, Adele, et al.
Publicado: (2010)

The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma
por: Tanyildiz, Hikmet Gulsah, et al.
Publicado: (2015)

Epstein-Barr Virus Latent Membrane Protein-1 Induces the Expression of SUMO-1 and SUMO-2/3 in LMP1-positive Lymphomas and Cells
por: Salahuddin, Sadia, et al.
Publicado: (2019)

Epstein–Barr virus LMP2A imposes sensitivity to apoptosis
por: Swanson-Mungerson, Michelle, et al.
Publicado: (2010)

Modulation of the tumor microenvironment by Epstein‐Barr virus latent membrane protein 1 in nasopharyngeal carcinoma
por: Yoshizaki, Tomokazu, et al.
Publicado: (2018)

Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma
por: GUO, LILI, et al.
Publicado: (2012)

Activation of sterol regulatory element‐binding protein 1 (SREBP1)‐mediated lipogenesis by the Epstein–Barr virus‐encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma
por: Lo, Angela Kwok‐Fung, et al.
Publicado: (2018)

Epstein-Barr Virus-Encoded LMP1 Interacts with FGD4 to Activate Cdc42 and Thereby Promote Migration of Nasopharyngeal Carcinoma Cells
por: Liu, Hao-Ping, et al.
Publicado: (2012)

Characterization of a Suppressive Cis-acting Element in the Epstein–Barr Virus LMP1 Promoter
por: Yoshida, Masahiro, et al.
Publicado: (2017)

Epstein-Barr Virus Latent Membrane Protein 2a (Lmp2a) Employs the Slp-65 Signaling Module
por: Engels, Niklas, et al.
Publicado: (2001)

The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer
por: Pang, Mei-Fong, et al.
Publicado: (2008)

Epstein-Barr Virus LMP2A Reduces Hyperactivation Induced by LMP1 to Restore Normal B Cell Phenotype in Transgenic Mice
por: Vrazo, Alexandra C., et al.
Publicado: (2012)

Epstein-Barr virus Latent Membrane Protein LMP1 reduces p53 protein levels independent of the PI3K-Akt pathway
por: Husaini, Roslina, et al.
Publicado: (2011)

RETRACTED ARTICLE: Cadherin 6 is activated by Epstein–Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma
por: Zuo, L-L, et al.
Publicado: (2017)

Retraction Note: Cadherin 6 is activated by Epstein–Barr virus LMP1 to mediate EMT and metastasis as an interplay node of multiple pathways in nasopharyngeal carcinoma
por: Zuo, L-L, et al.
Publicado: (2022)

Latent Membrane Protein 1 (LMP1) from Epstein–Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells
por: Müller Coan, Barbara G., et al.
Publicado: (2022)

Changes in Expression Induced by Epstein-Barr Virus LMP1-CTAR1: Potential Role of bcl3
por: Edwards, Rachel Hood, et al.
Publicado: (2015)

The Epstein-Barr Virus Oncoprotein, LMP1, Regulates the Function of SENP2, a SUMO-protease
por: Selby, Thomas L., et al.
Publicado: (2019)

A Meta-Analysis of the Diagnostic Accuracy of Two Commercial NS1 Antigen ELISA Tests for Early Dengue Virus Detection
por: da Costa, Vivaldo G., et al.
Publicado: (2014)

Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma
por: Yu, Ping-Hung, et al.
Publicado: (2013)

LMP1(+)SLAMF1(high) cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells
por: Yoon, Heejei, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u5qsksplkh8jvfn2po9mom1192